ASRT

Assertio Holdings Inc

Add to Watchlist

Advanced Chart

0.703

-0.007(-0.990%)

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

0.703351

Open

0.700

VWAP

0.70

Vol

139.31K

Mkt Cap

67.33M

Low

0.690

Amount

97.15K

EV/EBITDA(TTM)

12.33

Total Shares

95.12M

18.94M

EV/OCF(TTM)

2.98

P/S(TTM)

0.56

Assertio Holdings, Inc. is a commercial pharmaceutical company offering differentiated products to patients. The Company has built its commercial portfolio through acquisition or licensing of approved products. Its comprehensive commercial capabilities include marketing through both a sales force and a non-personal promotion model, market access through payor contracting and trade and distribution. The Company’s primary marketed products include ROLVEDONTM (eflapegrastim-xnst) injection for subcutaneous use, INDOCIN (indomethacin) Suppositories, INDOCIN (indomethacin) Oral Suspension, Sympazan (clobazam) oral film, Otrexup (methotrexate) injection for subcutaneous use, SPRIX (ketorolac tromethamine) Nasal Spray, CAMBIA (diclofenac potassium for oral solution) and Zipsor (diclofenac potassium) Liquid filled capsules. INDOCIN (indomethacin) Suppositories and INDOCIN (indomethacin) Oral Suspension products are nonsteroidal anti-inflammatory drugs (NSAID).

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2025Q3

FY2025Q2

30.06M

-6.6%

29.33M

+0.42%

27.86M

-10.5%

Estimates Revision

The market is revising Downward the revenue expectations for Assertio Holdings, Inc. (ASRT) for FY2025, with the revenue forecasts being adjusted by -0.63% over the past three months. During the same period, the stock price has changed by -11.42%.

Revenue Estimates for FY2025

Revise Downward

-0.63%

In Past 3 Month

Stock Price

Go Down

-11.42%

In Past 3 Month

5 Analyst Rating

298.29% Upside

Wall Street analysts forecast ASRT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ASRT is 2.80 USD with a low forecast of 1.50 USD and a high forecast of 3.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

1 Hold

0 Sell

Strong Buy

298.29% Upside

Current: 0.703

Low

1.50

Averages

2.80

High

3.50

298.29% Upside

Current: 0.703

Low

1.50

Averages

2.80

High

3.50

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Reiterates

$3.5

2025-05-19

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

$3.5

2025-05-19

Reiterates

Strong Buy

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Maintains

$4 → $3.5

2025-03-19

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

$4 → $3.5

2025-03-19

Maintains

Strong Buy

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Reiterates

2024-12-16

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

2024-12-16

Reiterates

Strong Buy

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Reiterates

2024-11-25

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

2024-11-25

Reiterates

Strong Buy

Reason

Maxim Group

Naz Rahman

Strong Buy

Initiates

2024-07-26

Reason

Maxim Group

Naz Rahman

Price Target

2024-07-26

Initiates

Strong Buy

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Strong Buy

Initiates

2024-07-03

Reason

HC Wainwright & Co.

Raghuram Selvaraju

Price Target

2024-07-03

Initiates

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Assertio Holdings Inc (ASRT.O) is -3.80, compared to its 5-year average forward P/E of 6.83. For a more detailed relative valuation and DCF analysis to assess Assertio Holdings Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

6.83

Current PE

-3.80

Overvalued PE

91.68

Undervalued PE

-78.02

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Undervalued

5Y Average EV/EBITDA

2.71

Current EV/EBITDA

1.05

Overvalued EV/EBITDA

4.18

Undervalued EV/EBITDA

1.23

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Fair

5Y Average PS

0.93

Current PS

0.52

Overvalued PS

1.36

Undervalued PS

0.50

Financials

Annual

Quarterly

FY2025Q1

YoY :

-18.37%

26.49M

Total Revenue

FY2025Q1

YoY :

+257.87%

-12.94M

Operating Profit

FY2025Q1

YoY :

+200.24%

-13.54M

Net Income after Tax

FY2025Q1

YoY :

+180.00%

-0.14

EPS - Diluted

FY2025Q1

YoY :

-267.00%

-12.54M

Free Cash Flow

FY2025Q1

YoY :

-25.83%

35.75

Gross Profit Margin - %

FY2025Q1

YoY :

-77.28%

5.35

FCF Margin - %

FY2025Q1

YoY :

+267.77%

-51.12

Net Margin - %

FY2025Q1

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

70.0K

USD

Months

0-12

35.4K

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

70.0K

USD

Months

0-12

35.4K

USD

Months

ASRT News & Events

Events Timeline

2024-12-17 (ET)

2024-12-17

07:34:13

Assertio Holdings appoints Mark Reisenauer to board of directors

2024-12-13 (ET)

2024-12-13

07:03:44

Assertio Holdings announces results of Rolvedon injection study

2024-12-12 (ET)

2024-12-12

07:05:59

Assertio Holdings appoints Schwichtenberg as CTO, Pietrya as CCO

News

4.0

05-19Benzinga

HC Wainwright & Co. Reiterates Buy on Assertio Holdings, Maintains $3.5 Price Target

9.5

05-12SeekingAlpha

Assertio Holdings GAAP EPS of -$0.14 misses by $0.08, revenue of $26.49M misses by $1.03M

3.0

05-11SeekingAlpha

Assertio Holdings Q1 2025 Earnings Preview

People Also Watch

Vigil Neuroscience Inc

Cayson Acquisition Corp

Auburn National Bancorporation Inc

Pathfinder Bancorp Inc (MARYLAND)

Alphatime Acquisition Corp

11.690

USD

-0.17%

FAQ

What is Assertio Holdings Inc (ASRT) stock price today?

The current price of ASRT is 0.703 USD — it has decreased -0.99 % in the last trading day.

ASRT

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

ASRT News & Events

Events Timeline

News

People Also Watch

FAQ

What is Assertio Holdings Inc (ASRT) stock price today?

What is Assertio Holdings Inc (ASRT)'s business?

What is the price predicton of ASRT Stock?

What is Assertio Holdings Inc (ASRT)'s revenue for the last quarter?

What is Assertio Holdings Inc (ASRT)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Assertio Holdings Inc (ASRT)'s fundamentals?

How many employees does Assertio Holdings Inc (ASRT). have?

What is Assertio Holdings Inc (ASRT) market cap?